Compare · MBAI vs NNOX
MBAI vs NNOX
Side-by-side comparison of Check-Cap Ltd. (MBAI) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MBAI and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- MBAI is the larger of the two at $90.5M, about 1.4x NNOX ($65.2M).
- Over the past year, MBAI is up 33.2% and NNOX is down 78.1% - MBAI leads by 111.3 points.
- MBAI has been more active in the news (12 items in the past 4 weeks vs 5 for NNOX).
- NNOX has more recent analyst coverage (4 ratings vs 0 for MBAI).
- Company
- Check-Cap Ltd.
- NANO-X IMAGING LTD
- Price
- $6.54-1.21%
- $0.83-1.84%
- Market cap
- $90.5M
- $65.2M
- 1M return
- -10.95%
- -14.66%
- 1Y return
- +33.19%
- -78.10%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- 2020
- News (4w)
- 12
- 5
- Recent ratings
- 0
- 4
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest MBAI
- SEC Form 6-K filed by Check-Cap Ltd.
- Check-Cap Completes MBody AI Merger, Closes $10 Million Underwritten Offering
- SEC Form 424B4 filed by Check-Cap Ltd.
- Check-Cap Ltd. Announces Pricing of $10 Million Public Offering of Ordinary Shares
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form EFFECT filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- Amendment: SEC Form F-1/A filed by Check-Cap Ltd.
- SEC Form 424B3 filed by Check-Cap Ltd.
- Check-Cap (MBAI) Advances Merger with MBody AI; Reverse Share Split Effective
Latest NNOX
- Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026
- Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
- SEC Form 6-K filed by NANO-X IMAGING LTD
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Chief Executive Officer Meltzer Erez bought $9,726 worth of Ordinary Shares (9,443 units at $1.03) (SEC Form 4)
- SEC Form 6-K filed by NANO-X IMAGING LTD
- SEC Form 424B5 filed by NANO-X IMAGING LTD
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Nano-X Imaging Ltd. Announces Pricing of a $8 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
- SEC Form 144 filed by NANO-X IMAGING LTD